However, the most important result is a significant 54% increase in ARHGAP26 gene expression in the BTZ-resistant U266 myeloma cells that were administered vitamin D and K three times compared to BTZ-resistant cells. Here, ARHGAP26 is linked to plasma cell myeloma.